Finch Trades

As of market close
February 27, 2026
Update frequency: every Saturday morning
Transaction
Position
Overall
Group
Year
Company
An icon graphic of an arrow.
Ticker
An icon graphic of an arrow.
Entry Date
An icon graphic of an arrow.
Group
An icon graphic of an arrow.
Status
An icon graphic of an arrow.
Cost Basis
An icon graphic of an arrow.
Last Price
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
Click individual row to view transaction details
Harmony Biosciences
$HRMY
2/20/26
Opportunistic
Active
Exited
9994
$30.75
$28.50
$1,750
$1,622
-7.3%
-7.4%
Harmony Biosciences
$HRMY
5/2/25
Current Compounder
Active
Exited
9995
$30.00
$28.50
$23,245
$22,083
-5.0%
-25.7%
Exact Sciences
$EXAS
4/30/25
Opportunistic
Active
Exited
9999
$44.69
$53.05
$10,000
$11,871
18.7%
14.9%
Blueprint Medicines
$BPMC
4/30/25
Opportunistic
Active
Exited
10000
$88.21
$98.73
$10,000
$11,193
11.9%
8.9%
Coherus Oncology
$CHRS
3/27/25
Future Compounder
Active
Exited
$0.86
$1.67
$250
$486
94.4%
73.4%
Coherus Oncology
$CHRS
1/21/25
Future Compounder
Active
Exited
$1.37
$1.67
$1,000
$1,219
21.9%
8.1%
Relay Therapeutics
$RLAY
1/10/25
Future Compounder
Active
Exited
$4.32
$10.26
$7,000
$16,633
137.6%
119.4%
AVITA Medical
$RCEL
1/8/25
Future Compounder
Active
Exited
9998
$9.53
$7.45
$1,000
$782
-21.8%
-18.5%
Relay Therapeutics
$RLAY
12/10/24
Future Compounder
Active
Exited
$4.44
$10.26
$2,500
$5,771
130.8%
117.0%
Relay Therapeutics
$RLAY
12/3/24
Future Compounder
Active
Exited
$4.45
$10.26
$2,500
$5,771
130.8%
117.2%
Relay Therapeutics
$RLAY
11/20/24
Future Compounder
Active
Exited
$4.55
$10.26
$2,000
$4,511
125.5%
109.4%
Relay Therapeutics
$RLAY
10/29/24
Future Compounder
Active
Exited
$5.80
$10.26
$1,000
$1,770
77.0%
59.1%
Arrowhead Pharma
$ARWR
10/1/24
Future Compounder
Active
Exited
9996
$18.48
$63.64
$1,000
$3,444
244.4%
224.2%
Relay Therapeutics
$RLAY
9/25/24
Future Compounder
Active
Exited
$7.00
$10.26
$725
$1,063
46.6%
26.2%
Arrowhead Pharma
$ARWR
9/25/24
Future Compounder
Active
Exited
9997
$19.48
$63.64
$1,000
$3,268
226.8%
206.9%
Relay Therapeutics
$RLAY
9/13/24
Future Compounder
Active
Exited
$7.55
$10.26
$1,000
$1,359
35.9%
13.8%
Relay Therapeutics
$RLAY
9/5/24
Future Compounder
Active
Exited
$6.18
$10.26
$2,000
$3,320
66.0%
41.2%
Coherus Oncology
$CHRS
7/2/24
Future Compounder
Active
Exited
$1.40
$1.67
$1,000
$1,197
19.7%
-5.2%
Exact Sciences
$EXAS
5/29/24
Current Compounder
Active
Exited
$44.98
$103.38
$1,000
$2,298
129.8%
99.4%
Relay Therapeutics
$RLAY
5/29/24
Future Compounder
Active
Exited
$6.28
$10.26
$1,000
$1,635
63.5%
33.1%
Coherus Oncology
$CHRS
4/25/24
Future Compounder
Active
Exited
$1.93
$1.67
$6,996
$6,054
-13.5%
-49.7%
Position
An icon graphic of an arrow.
Ticker
An icon graphic of an arrow.
Group
An icon graphic of an arrow.
Status
An icon graphic of an arrow.
Shares
An icon graphic of an arrow.
Cost Basis
An icon graphic of an arrow.
Last Price
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
Click individual row to view position details
Relay Therapeutics
$RLAY
Future Compounder
Building
Building
Building
1
4,077.2
$4.84
$10.26
$19,725
$41,832
112.1%
93.7%
Coherus Oncology
$CHRS
Future Compounder
Building
Building
Building
2
5,362.8
$1.72
$1.67
$9,246
$8,956
-3.1%
-35.3%
Exact Sciences
$EXAS
Current Compounder
Full
Full
Full
994
22.2
$44.98
$103.38
$1,000
$2,298
129.8%
99.4%
Harmony Biosciences
$HRMY
Opportunistic
Exited
Exited
Exited
995
56.9
$30.75
$28.50
$1,750
$1,622
-7.3%
-7.4%
Harmony Biosciences
$HRMY
Current Compounder
Exited
Exited
Exited
996
774.8
$30.00
$28.50
$23,245
$22,083
-5.0%
-25.7%
Arrowhead Pharma
$ARWR
Future Compounder
Exited
Exited
Exited
997
105.5
$18.96
$63.64
$2,000
$6,712
235.6%
206.9%
AVITA Medical
$RCEL
Future Compounder
Exited
Exited
Exited
998
104.9
$9.53
$7.45
$1,000
$782
-21.8%
-18.3%
Exact Sciences
$EXAS
Opportunistic
Exited
Exited
Exited
999
223.8
$44.69
$53.05
$10,000
$11,871
18.7%
14.9%
Blueprint Medicines
$BPMC
Opportunistic
Exited
Exited
Exited
1000
113.4
$88.21
$98.73
$10,000
$11,193
11.9%
8.9%
Principal
$53,153
Current Value
$82,534
Total Return
55.3%
CAGR
(from April 2024)
27.0%
Benchmark
An icon graphic of an arrow.
Ticker
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Current Value
An icon graphic of an arrow.
$ Change
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
Finch Trades vs.
An icon graphic of an arrow.
Finch Trades
$FINCH
$53,153
$82,534
$29,382
55.3%
0.0%
If S&P 500
$SPY
$53,153
$65,433
$12,281
23.1%
32.2%
If XBI
$XBI
$53,153
$76,388
$23,235
43.7%
11.6%
If Nasdaq 100
$QQQ
$53,153
$67,421
$14,268
26.8%
28.4%
If ARKG
$ARKG
$53,153
$66,920
$13,768
25.9%
29.4%
Group
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
vs. QQQ
An icon graphic of an arrow.
vs. XBI
An icon graphic of an arrow.
vs. ARKG
An icon graphic of an arrow.
Future Compounder
$30,971
$57,500
85.7%
60.5%
56.5%
44.2%
60.7%
Opportunistic
$21,750
$24,688
13.5%
10.3%
11.6%
13.3%
13.0%
Current Compounder
$24,245
$24,381
0.6%
-20.4%
-23.9%
-51.6%
-31.1%
* This view tracks performance by the portfolio allocation group without accounting for reinvested proceeds.
Year
An icon graphic of an arrow.
Principal
An icon graphic of an arrow.
Last Value
An icon graphic of an arrow.
% Change
An icon graphic of an arrow.
vs. SPY
An icon graphic of an arrow.
vs. QQQ
An icon graphic of an arrow.
vs. XBI
An icon graphic of an arrow.
vs. ARKG
An icon graphic of an arrow.
2024
$23,721
$41,461
74.8%
50.1%
44.0%
35.6%
51.4%
2025
$52,495
$64,296
22.5%
9.3%
8.0%
-7.2%
5.1%
2026
$1,750
$1,624
-7.2%
-7.3%
-7.8%
-9.3%
-8.5%
* This view tracks performance by the year principal was invested without accounting for reinvested proceeds.
Research Notes
MOS Dashboard
ABOUT
What Is Solt DB?
Public Benefit
Our Lonely Team
PUBLIC CONTENT
Articles
Data Visualizations
Newsletter
INVESTING
Pricing
Member Benefits
Stocks We Cover
CONTACT
Questions?
Critiques?
Love letters?

Reach out here.
About Solt DB

Solt DB is an equities research firm and public benefit company exploring the business of biotech. For scientists, investors, and nerds of all stripes -- or feathers.

Yinz respect the finch n@. 2026 Solt DB.
A white logo of LinkedIn.